InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,539.11
(
1.54%
)
US TECH 100
18,986.80
(
2.58%
)
Dow Jones
40,548.90
(
1.35%
)
Brent Oil
80.45
(
1.04%
)
Bitcoin
57,187.21
(
-2.61%
)
Post# of 252896
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Summer2762

Send PM Follow Ignore
Followers 7
Posts 193
Boards Moderated 0
Alias Born 10/26/2011

Summer2762

Re: mcbio post# 148102

Monday, 09/03/2012 2:05:54 PM

Monday, September 03, 2012 2:05:54 PM

Post# of 252896
There is also this possibility in case anyone missed it

http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=76766

--

IMO, the major issue in investing in OGXI at this moment is that we dont know how these approvals (of abi after (& before?) chemo & mdv3100 after chemo) will mess up the existing OGX trials, especially the SYNERGY trial, which is open label. Even though I trust TEVA, I am not sure if even TEVA can skirt around the interaction issues.

Otherwise, I don't share the other expressed concerns (there is no money/time/room for another drug, OGX-011 & 427 are antisense drugs or the chemo in mCRPC going away).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up